About Lepu Medical Technology
Lepu Medical Technology is a company based in Beijing (China) founded in 1999. The company has 8,810 employees as of December 31, 2024. Lepu Medical Technology operates in a competitive market with competitors including GEN inCode, SD Biosensor, SpectraWAVE, Spectrum Dynamics and Proxim Diagnostics, among others.
- Headquarter Beijing, China
- Employees 8810 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lepu Medical Technology (Beijing) Co., Ltd. Class A
-
Annual Revenue
$824.73 M (USD)-23.67as on Dec 31, 2024
-
Net Profit
$33.83 M (USD)-80.37as on Dec 31, 2024
-
EBITDA
$146.59 M (USD)-50.56as on Dec 31, 2024
-
Latest Funding Round
$185.83 M (USD), Post-IPO
Aug 06, 2020
-
Investors
Haitong Securities
& 6 more
-
Employee Count
8810
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Lepu Medical Technology
Lepu Medical Technology is a publicly listed company on the SZSE with ticker symbol 300003 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Lepu Medical Technology
Investors in Lepu Medical Technology
Lepu Medical Technology has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Haitong Securities, RiverHead Capital and SDIC Unity Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
A professional guiding and industrial fund management institution is operated.
|
Locked | Locked | Locked | |
|
Technology, manufacturing, healthcare, and consumer companies are provided growth equity.
|
Locked | Locked | Locked |
Investor details for Lepu Medical Technology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lepu Medical Technology
Investment portfolio details for Lepu Medical Technology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lepu Medical Technology
Detailed financials for Lepu Medical Technology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lepu Medical Technology Comparisons
Peer comparison for Lepu Medical Technology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lepu Medical Technology
Lepu Medical Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GEN inCode, SD Biosensor, SpectraWAVE, Spectrum Dynamics and Proxim Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genetic and clinical data are integrated for precision cardiac medicines.
|
|
| Locked | Locked | Locked |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| Locked | Locked | Locked |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| Locked | Locked | Locked |
Cardiac imaging systems are manufactured using advanced molecular technologies.
|
|
| Locked | Locked | Locked |
Handheld immunodiagnostic devices for cardiac vascular diseases are developed.
|
Detailed competitors of Lepu Medical Technology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lepu Medical Technology
Complete news archive for Lepu Medical Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lepu Medical Technology
Lepu Medical Technology was founded in 1999 and raised its 1st funding round 20 years after it was founded.
Lepu Medical Technology is headquartered in Beijing, China.
Pu Zhongjie is the current CEO of Lepu Medical Technology.
As of Dec 31, 2024, the latest employee count at Lepu Medical Technology is 8,810.
Annual revenue of Lepu Medical Technology is $824.73M as on Dec 31, 2024.
Lepu Medical Technology is engaged in the development, manufacturing, and marketing of cardiac therapy related products. The company offers products under eight main categories: Interventional cardiology (Stent, Balloon, Catheter, and Guidewire); Structural heart disease (occlusion devices, prosthetic heart valves); Heart rhythm (Electrophysiology catheter, Implantable pacemaker, Pacemaker lead); cardiac in vitro diagnosis products (analyzer, cardiac biomarkers test cassette, Thrombelastography hemostasis analyzer), Anesthetic products, Interventional angiography system, Surgical stapler, and Neurological intervention products. The company has 7 wholly-owned and joint stock subsidiary companies.
Lepu Medical Technology's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.
Yes, Lepu Medical Technology is publicly traded on SZSE under the ticker symbol 300003.
Lepu Medical Technology has 7 investors. Key investors include Haitong Securities, RiverHead Capital, SDIC Unity Capital, China Reform Fund Management, and Shiyu Capital.
The ticker symbol of Lepu Medical Technology is 300003 on SZSE.